These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 10110041)

  • 21. A drug information service quality assurance audit.
    Hart LL; Miwa LJ; Millares M
    Hosp Formul; 1989 Jul; 24(7):383-6, 388-9. PubMed ID: 10293845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quality assurance and certification program for an aminoglycoside monitoring service.
    Shevchuk YM; Poulin S
    Can J Hosp Pharm; 1990 Apr; 43(2):49-55. PubMed ID: 10106632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quality assurance of pharmaceutical services in hospitals.
    Johnson RE; Campbell WH; Christensen DB
    Am J Hosp Pharm; 1974 Jul; 31(7):640-7. PubMed ID: 4853986
    [No Abstract]   [Full Text] [Related]  

  • 24. Quality assurance program for a clinical pharmacokinetic service.
    Lawson LA; Blouin RA; Parker PF
    Am J Hosp Pharm; 1982 Apr; 39(4):607-9. PubMed ID: 7081236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Self-study program on drug information for staff pharmacists.
    Poirier TI; Lech JG
    Am J Hosp Pharm; 1982 Aug; 39(8):1313-5. PubMed ID: 7124752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Setting up a peer review process for community-based organizations: conflicts and challenges.
    Wright MT; Lemmen K; Block M; von Unger H
    Prog Community Health Partnersh; 2008; 2(2):121-7. PubMed ID: 20208245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of generic screening criteria for clinical interventions that link prescribing to credentialing.
    Mustion AL; Sobotka J
    Hosp Pharm; 1991 Nov; 26(11):968-72, 1015. PubMed ID: 10114824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physician peer assessments for compliance with methadone maintenance treatment guidelines.
    Strike C; Wenghofer E; Gnam W; Hillier W; Veldhuizen S; Millson M
    J Contin Educ Health Prof; 2007; 27(4):208-13. PubMed ID: 18085599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The integration of quality assessment and a patient-specific intervention/outcomes program.
    Mutnick AH; Sterba KJ; Szymusiak-Mutnick BA
    Pharm Pract Manag Q; 1998 Jan; 17(4):25-36. PubMed ID: 10174746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug newsletters and quality assurance of drug usage.
    Plumridge RJ; Greenhill GT; Blackbourn J
    Hosp Pharm; 1988 Aug; 23(8):718, 720-4, 729. PubMed ID: 10288921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quality assurance program for a nuclear pharmacy.
    Hiltz A; Pierce S
    Can J Hosp Pharm; 1991 Feb; 44(1):25-9. PubMed ID: 10110040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving drug use through purchase agreement commitments.
    Keys P; Stierer RC; Sterchele JA; Tarasovic CF; Horner LB
    Am J Hosp Pharm; 1993 Jul; 50(7):1423-4. PubMed ID: 8362877
    [No Abstract]   [Full Text] [Related]  

  • 33. RADPEER quality assurance program: a multifacility study of interpretive disagreement rates.
    Borgstede JP; Lewis RS; Bhargavan M; Sunshine JH
    J Am Coll Radiol; 2004 Jan; 1(1):59-65. PubMed ID: 17411521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quality of care evaluation applied to assessment of clinical pharmacy services.
    Keys PW; South JC; Duffy MG
    Am J Hosp Pharm; 1975 Sep; 32(9):897-902. PubMed ID: 1190245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Documenting the activity and effectiveness of a regional drug information center.
    Golightly LK; Davis AG; Budwitz WJ; Gelman CJ; Rathmann KL; Sutherland EW; Rumack BH
    Am J Hosp Pharm; 1988 Feb; 45(2):356-61. PubMed ID: 3364436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Further development of peer-review-procedures in medical rehabilitation].
    Farin E; Carl C; Jäckel WH; Rütten-Köppel E; Maier-Riehle B; Berghaus U
    Rehabilitation (Stuttg); 2004 Jun; 43(3):162-5. PubMed ID: 15202040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A system for documentation of pharmacist interventions with incorporation into performance and quality improvement plans.
    Brown BL; Williamson SE
    Hosp Pharm; 1993 Nov; 28(11):1083-4, 1086-8. PubMed ID: 10130385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physician assessment of pharmacists' interventions--a method of estimating cost avoidance and determining quality assurance.
    Bayliff CD; Einarson TR
    Can J Hosp Pharm; 1990 Aug; 43(4):167-71, 195. PubMed ID: 10105985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Warfarin: a quality assurance model for concurrent drug monitoring.
    Mattei TJ; Karnack CM; Rihn TL; Eder RA
    Hosp Pharm; 1985 Apr; 20(4):235-7, 240-1. PubMed ID: 10270729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Timeliness of receipt of manufacturers' new product information.
    Murdoch LA; Lum L
    Can J Hosp Pharm; 1991 Oct; 44(5):235-8. PubMed ID: 10115576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.